Blood-Grouping Reagents Market

The global market for blood-grouping reagents is expected to show growth in both consumption and value terms from 2022 to 2030, with a projected CAGR of +0.6% and +2.6% respectively. Russia dominates both production and consumption of blood-grouping reagents, with significant growth rates over the past decade. The market also sees steady growth in global exports and imports, with major exporting countries including the United States, the UK, and China. The average export price per ton has shown a slight decrease in 2022, with notable differences in prices among major exporting countries. Overall, the market for blood-grouping reagents is set to continue its upward trend in the coming years.

Market Forecast

Driven by increasing demand for blood-grouping reagents worldwide, the market is expected to continue an upward consumption trend over the next eight-year period. Market performance is forecast to decelerate, expanding with an anticipated CAGR of +0.6% for the period from 2022 to 2030, which is projected to bring the market volume to 135K tons by the end of 2030.

In value terms, the market is forecast to increase with an anticipated CAGR of +2.6% for the period from 2022 to 2030, which is projected to bring the market value to $20.2B (in nominal prices) by the end of 2030.

Consumption

World Consumption of Blood-Grouping Reagents

In 2022, global consumption of blood-grouping reagents soared to 129K tons, with an increase of 23% against the year before. Overall, consumption saw a strong expansion. Global consumption peaked in 2022 and is expected to retain growth in years to come.

The global blood-grouping reagents market size soared to $16.4B in 2022, picking up by 25% against the previous year. This figure reflects the total revenues of producers and importers (excluding logistics costs, retail marketing costs, and retailers' margins, which will be included in the final consumer price). Over the period under review, consumption recorded a resilient expansion. Global consumption peaked in 2022 and is likely to see steady growth in the immediate term.

Consumption By Country

The country with the largest volume of blood-grouping reagents consumption was Russia (93K tons), comprising approx. 72% of total volume. Moreover, blood-grouping reagents consumption in Russia exceeded the figures recorded by the second-largest consumer, China (8.9K tons), tenfold. The third position in this ranking was held by the United States (4.6K tons), with a 3.6% share.

In Russia, blood-grouping reagents consumption increased at an average annual rate of +20.7% over the period from 2012-2022. The remaining consuming countries recorded the following average annual rates of consumption growth: China (+0.6% per year) and the United States (+2.7% per year).

In value terms, Russia ($13B) led the market, alone. The second position in the ranking was held by Germany ($752M). It was followed by Japan.

In Russia, the blood-grouping reagents market expanded at an average annual rate of +20.2% over the period from 2012-2022. The remaining consuming countries recorded the following average annual rates of market growth: Germany (+5.6% per year) and Japan (-6.8% per year).

The countries with the highest levels of blood-grouping reagents per capita consumption in 2022 were Germany (32 kg per 1000 persons), Japan (16 kg per 1000 persons) and the United States (14 kg per 1000 persons). Moreover, blood-grouping reagents per capita consumption in Germany exceeded the figures recorded by the world's second-largest consumer, Japan, twofold.

From 2012 to 2022, the most notable rate of growth in terms of consumption, amongst the leading consuming countries, was attained by Russia (with a CAGR of +20.6%), while consumption for the other global leaders experienced more modest paces of growth.

Production

World Production of Blood-Grouping Reagents

For the ninth year in a row, the global market recorded growth in production of blood-grouping reagents, which increased by 23% to 130K tons in 2022. Over the period under review, production showed a strong increase. The pace of growth was the most pronounced in 2021 with an increase of 28% against the previous year. Global production peaked in 2022 and is likely to see steady growth in the immediate term.

In value terms, blood-grouping reagents production contracted modestly to $7.4B in 2022 estimated in export price. Overall, production showed a noticeable expansion. The pace of growth appeared the most rapid in 2016 when the production volume increased by 69%. As a result, production reached the peak level of $11.2B. From 2017 to 2022, global production growth remained at a somewhat lower figure.

Production By Country

Russia (93K tons) remains the largest blood-grouping reagents producing country worldwide, accounting for 72% of total volume. Moreover, blood-grouping reagents production in Russia exceeded the figures recorded by the second-largest producer, China (9.3K tons), tenfold. The United States (5.4K tons) ranked third in terms of total production with a 4.2% share.

In Russia, blood-grouping reagents production expanded at an average annual rate of +20.7% over the period from 2012-2022. In the other countries, the average annual rates were as follows: China (+0.8% per year) and the United States (+0.1% per year).

Imports

World Imports of Blood-Grouping Reagents

In 2022, global blood-grouping reagents imports fell slightly to 3.7K tons, shrinking by -2.1% compared with 2021. Over the period under review, imports saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2014 with an increase of 14% against the previous year. As a result, imports reached the peak of 4.2K tons. From 2015 to 2022, the growth of global imports remained at a lower figure.

In value terms, blood-grouping reagents imports declined modestly to $506M in 2022. In general, imports saw a relatively flat trend pattern. The pace of growth was the most pronounced in 2020 when imports increased by 12% against the previous year. As a result, imports reached the peak of $530M. From 2021 to 2022, the growth of global imports remained at a lower figure.

Imports By Country

The countries with the highest levels of blood-grouping reagents imports in 2022 were France (426 tons), Germany (324 tons) and China (301 tons), together reaching 28% of total import. It was followed by Saudi Arabia (184 tons), making up a 4.9% share of total imports. The following importers - Italy (168 tons), the United States (164 tons), Bulgaria (146 tons), Spain (136 tons), the UK (124 tons), Cyprus (90 tons), Japan (87 tons), Chile (86 tons) and Poland (83 tons) - together made up 29% of total imports.

From 2012 to 2022, the biggest increases were recorded for Bulgaria (with a CAGR of +43.7%), while purchases for the other global leaders experienced more modest paces of growth.

In value terms, the largest blood-grouping reagents importing markets worldwide were China ($53M), the United States ($47M) and France ($36M), with a combined 27% share of global imports. Germany, Saudi Arabia, Italy, Japan, Spain, the UK, Bulgaria, Poland, Chile and Cyprus lagged somewhat behind, together comprising a further 31%.

Bulgaria, with a CAGR of +29.5%, recorded the highest growth rate of the value of imports, in terms of the main importing countries over the period under review, while purchases for the other global leaders experienced more modest paces of growth.

Import Prices By Country

The average blood-grouping reagents import price stood at $135,158 per ton in 2022, standing approx. at the previous year. Over the period under review, the import price, however, recorded a relatively flat trend pattern. The pace of growth was the most pronounced in 2018 an increase of 5.6% against the previous year. Over the period under review, average import prices attained the peak figure at $135,959 per ton in 2021, and then declined in the following year.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was the United States ($286,517 per ton), while Cyprus ($21,304 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Saudi Arabia (+4.2%), while the other global leaders experienced more modest paces of growth.

Exports

World Exports of Blood-Grouping Reagents

In 2022, shipments abroad of blood-grouping reagents was finally on the rise to reach 4.8K tons for the first time since 2019, thus ending a two-year declining trend. In general, exports saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2019 with an increase of 16% against the previous year. As a result, the exports attained the peak of 5.4K tons. From 2020 to 2022, the growth of the global exports remained at a lower figure.

In value terms, blood-grouping reagents exports reduced slightly to $500M in 2022. Over the period under review, exports, however, saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2018 with an increase of 8.4% against the previous year. Over the period under review, the global exports hit record highs at $518M in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

Exports By Country

In 2022, the United States (955 tons), the UK (926 tons), Switzerland (899 tons) and China (727 tons) represented the largest exporter of blood-grouping reagents in the world, mixing up 73% of total export. Spain (482 tons) ranks next in terms of the total exports with a 10% share, followed by France (5.6%) and Germany (5.3%).

From 2012 to 2022, the most notable rate of growth in terms of shipments, amongst the key exporting countries, was attained by the UK (with a CAGR of +11.1%), while the other global leaders experienced more modest paces of growth.

In value terms, the largest blood-grouping reagents supplying countries worldwide were Switzerland ($112M), the United States ($90M) and Germany ($66M), together accounting for 54% of global exports. Spain, the UK, France and China lagged somewhat behind, together accounting for a further 35%.

China, with a CAGR of +6.9%, recorded the highest growth rate of the value of exports, in terms of the main exporting countries over the period under review, while shipments for the other global leaders experienced more modest paces of growth.

Export Prices By Country

The average blood-grouping reagents export price stood at $103,438 per ton in 2022, falling by -7% against the previous year. Over the period under review, the export price continues to indicate a slight decrease. The growth pace was the most rapid in 2014 when the average export price increased by 17% against the previous year. As a result, the export price reached the peak level of $115,456 per ton. From 2015 to 2022, the average export prices remained at a somewhat lower figure.

There were significant differences in the average prices amongst the major exporting countries. In 2022, amid the top suppliers, the country with the highest price was Germany ($254,245 per ton), while China ($1,345 per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by France (+4.2%), while the other global leaders experienced more modest paces of growth.

Source: IndexBox Market Intelligence Platform